Show Notes
In this episode of This Could Save Your Life podcast, Dr Catherine Bourke discusses the new lung cancer screening program in Australia and its importance for early cancer detection. Dr Bourke explains that lung cancer remains the leading cause of cancer-related death in Australia, largely because most cases are detected too late. She reviews recent evidence supporting screening, such as the Nelson Study and National Lung Screening Trial, which show significant reductions in mortality with the use of low-dose CT. Key eligibility criteria for the screening program are ages 50–70, current or recent smokers (within 10 years of quitting), and a history of at least 30 pack-years. Providing guidance on enrolment, the screening process, and clarifies pack-year calculation. She also addresses misconceptions about lung cancer only affecting smokers and explores the impact of stigma and nicotine dependence. Detailing the essentials for general practice, including how to refer patients, what to expect from the CT scan process, and how results and nodule management protocols inform follow-up and specialist referral. GPs are encouraged to support eligible patients to participate for better outcomes through early detection and advances in lung cancer treatment. Links & Resources: The heart of Australia: https://heartofaustralia.com.au/ National lung cancer cancer screening program: https://www.health.gov.au/our-work/nlcsp?gclsrc=aw.ds&gad_source=1&gad_campaignid=23576447207&gbraid=0AAAAA_Hdu8ldTc75J8nw1zqot-Q-9Peic&gclid=Cj0KCQjw7IjOBhDyARIsAFzrWQz0u-84xCTnyQspBM7pE0tkVszhnlnMuCMcyRVZOJ8uSpoG3AjwAUwaAkBoEALw_wcB
This Could Save Your Life Podcast is under The Good GP podcast, a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network If you have any questions or would like to contact The Good GP, send an email to [email protected]. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our Instagram page: @thegoodgppodcast. Follow us for more updates!
More from The Good GP
In this episode of The Good GP, Dr Krystyna de Lange speaks with Dr Steph Daly, GP with a special interest in aged care and dementia, about the introduction of plasma biomarkers, specifically the p-Tau 217 blood test for Alzheimer’s disease. They explore what the p-Tau 217 test measures, its reliability, and its role in primary care.
In this episode of The Good GP, host Dr Krystyna De Lange speaks with Dr David Leitinger, a GP with a special interest in addiction medicine, about the practical use of naltrexone for managing alcohol use disorder (AUD).
In this episode of The Good GP, Dr Julia Rawlinson speaks with Dr Florence Martin, an epidemiologist specialising in pregnancy pharmacoepidemiology. Dr Martin discusses her recent study examining the relationship between first trimester antidepressant use and miscarriage risk, using UK primary care data from the CPRD GOLD database.
In this episode of the Good GP, Dr Julia Rawlinson speaks with Dr Julia Feutrill, consultant psychiatrist at King Edward Memorial Hospital and co-director of the Elizabeth Clinic. They discuss the complexities of antidepressant use during pregnancy, providing GPs with practical advice for navigating these conversations.
In this episode of the Good GP, Dr Julia Rawlinson speaks with Dr Paul Effler, Senior Medical Advisor at the WA Department of Health and expert in communicable diseases, about H5N1 avian influenza and pertussis.